Target RNA‐directed miRNA Degradation (TDMD) Platform

About Chimerna Therapeutics

Chimerna Therapeutics is a private biotech focused on unlocking the therapeutic potential of RNA through its innovative Tornado circularization platform. This technology allows cells to produce stable, circular RNAs that resist degradation, enabling the development of RNA aptamers, sponges, and other modalities for intracellular targets. The company is advancing its own pipeline in areas like Alzheimer's and NASH while also developing platform technologies to accelerate external drug discovery efforts, particularly in microRNA biology and recombinant protein production.

Therapeutic Areas